:

Kamil Kośmider1,2, Agata Kozakiewicz3, Paweł Krawczyk1

  • 1Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.

ImmunoTargets and therapy
|December 25, 2025
PubMed
概括

人类白细胞抗原 (HLA) 基因变异与免疫检查点抑制剂 (ICI) 治疗癌症期间的免疫相关不良事件 (irAEs) 有关. 通过预测irAE风险,HLA基因型定型可以个性化治疗,并提高患者的安全性.